🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 40% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

2 Softgel Capsule(s) Serving Size
30 Servings
Other Combinations Product Type
40% Evidence Coverage

Supplement Facts — Evidence Check

Calories
15 Calorie(s)
Total Fat
1.5 Gram(s) (2% DV)
📊 Market median: 750.0mg (447 products) 📚 388 studies (Tier A: 18, B: 204)
This product: 1065mg UL 3000mg
Levagen Palmitic Acid Monoethanolamide
300 mg
📊 Market median: 375.0mg (171 products) 📚 30 studies (Tier A: 1, B: 14)
This product: 100mg

Other Ingredients

Fish Oil Gelatin Glycerin Beeswax Enteric Coating Silicon Dioxide Soy Lecithin Titanium Dioxide Mixed Tocopherols Chlorophyll

Label Claims — Verification

Nutrient
All Other
Structure/Function
All Other (99% of products) Structure/Function (86% of products) Nutrient (79% of products) Qualified Health (13% of products) Approved Health (2% of products)

Target Groups

Adult (18 - 50 Years) Gluten Free Dairy Free Sugar Free

Product Information

📋 Directions for Use

Directions: As a dietary supplement, take one softgel capsule twice daily with food.

⚠️ Warnings & Precautions

Contains: Soybeans and Fish (Anchovy, Mackerel, Sardine, Smelt, Salmon, Tuna, Cod or a Combination thereof.)

🧪 Formulation Notes

GNC Triple Strength Fish Oil Plus Joint combines premium ingredients that support joint health.

Triple Strength Fish Oil Our Triple Strength Fish Oil is packed with Omega-3s, including EPA, which supports joint and health and the body's natural anti-inflammatory response. What's more, EPA supports heart and circulatory health, as well as normal, healthy triglyceride and cholesterol levels. Omega-3s also provide support for healthy vision, brain development and skin health. ApresFlex and Levagen ApresFlex is a potent boswellia serrata extract, which is clinically proven to support a 7 times greater improvement in joint comfort, as well as improvements in joint stiffness and function, in as few as 5 days. It is thought to work by targeting pathways related to your body's natural anti-inflammatory response. Levagen supports a healthy response to inflammation and may support comfort.

1000 mg of EPA/DHA Omega-3s & clinically proven joint support

Contains: Soybeans and Fish (Anchovy, Mackerel, Sardine, Smelt, Salmon, Tuna, Cod or a Combination thereof.)

No Sugar, No Starch, No Artificial Flavors, No Wheat, Gluten Free, No Corn, No Dairy.

Free from detectable levels of mercury, lead, heavy metals and PCBs

From wild, deep ocean fish

Additional Information

Our quality commitment to you Since 1935, our mission as the industry leader has been to provide you with the highest-quality nutritional supplements. We continue to stand behind this mission. If you're not 100% satisfied with your purchase, return the unused portion of the product with your receipt within 30 days and we'll either refund your money or find you a replacement product that is right for you.

In a 30 day, randomized, double-blind, placebo-controlled study of 67 adults, subjects taking 50 mg of ApresFlex twice daily experienced a statistically significant difference in mean improvements from baseline for joint comfort, stiffness and function as measured by WOMAC that was 7.5 and 43 times greater in the ApresFlex group than placebo, respectively, after 30 days. Statistically significant improvements were seen as early as 5 days.

Improves joint comfort & stiffness in as few as 5 days

Certified purified

CODE 736321 ESG

Potency verified by GNC procedure #5123. Conforms to USP <2091> for weight.

Enteric coated to help control fishy burps = guaranteed

Gf Gluten free

Product Details

DSLD Entry Date 2018-11-21
Product Type Other Combinations
Form Softgel Capsule
Brand GNC
DSLD ID 183171
Data Updated 2026-04-11

Research Evidence

495 Research Sources
56 Avg Quality Score
222 Meta Analysis
104 Clinical Trial
72 Rct
69 Systematic Review
11 Guideline
5 Cochrane Review
5 Regulatory Source
3 Narrative Review
1 Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
View all evidence for Omega 3 →

Compare Similar Products

View all Omega 3 products →